Electra Therapeutics prices its IPO at $15 per share, aiming to raise approximately $350 million for its precision medicine developments. Electra Therapeutics, Inc., a biopharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results